Jane F. Barlow - 16 Aug 2021 Form 4 Insider Report for Viracta Therapeutics, Inc. (VIRX)

Role
Director
Signature
/s/ Michael Mueller, as Attorney-in-Fact
Issuer symbol
VIRX
Transactions as of
16 Aug 2021
Transactions value $
$0
Form type
4
Filing time
17 Aug 2021, 18:10:28 UTC
Previous filing
17 Aug 2021
Next filing
12 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRX Stock Option (Right to Buy) Award $0 +80K $0.00 80K 16 Aug 2021 Common Stock 80K $9.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One thirty-sixth (1/36) of the shares subject to the option shall vest monthly beginning on the one month anniversary of August 16, 2021 (the "Vesting Commencement Date"), subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date.